Comments on: Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair

Comments on: Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair https://uptodatehealthfacts.org/neuraptive-therapeutics-inc-announces-first-patient-enrolled-in-phase-3-clinical-trial-evaluating-the-safety-and-efficacy-of-ntx-001-compared-to-standard-of-care-in-the-treatment-of-upper-extremity/2638/ Fri, 03 Oct 2025 05:10:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4